Ethyl loflazepate
From Wikipedia, the free encyclopedia
 |
|
 |
|
|
Ethyl loflazepate
|
|
| Systematic (IUPAC) name | |
| ethyl-9-chloro-6-(2-fluorophenyl)-3-oxo-2,5-diazabicyclo [5.4.0]undeca-5,8,10,12-tetraene-4-carboxylate |
|
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C18H14ClFN2O3 |
| Mol. mass | 360.7 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Ethyl loflazepate (marketed under brand name Meilax) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties.
[edit] External links
- (Japanese) Meilax Fine Granules
|
|||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
